Monday, July 17, 2006
Dr. Patrick Bitter's phenyl-epinephrine rosacea patent
Dr. Bitter (creator of the "PhotoFacial" protocol) has submitted a patent application for the use of a topical constrictor, post-IPL treatments, or as a cosmetic lotion (to reduce redness). Most patents don't result in commercial products/treatments being developed, but interesting nonetheless.
Topical phenyl-epinephrine Rosacea treatment
Quote:
Inventors: Bitter, Patrick H. SR.; (Los Gatos, CA)
A near-permanent skin treatment includes photothermolysis of reddened facial skin to induce ischemia. Reperfusion of the photothermolysis treated skin is inhibited by following with regular applications of phenyl-epinephrine carried in a lotion until vascular necrosis is complete. Alternatively, a temporary treatment for reddened facial skin includes only cosmetic as-needed applications of phenyl-epinephrine carried in lotion to induce vasoconstriction in Rosacea and other similarly embarrassing skin disorders.
Topical phenyl-epinephrine Rosacea treatment
Quote:
Inventors: Bitter, Patrick H. SR.; (Los Gatos, CA)
A near-permanent skin treatment includes photothermolysis of reddened facial skin to induce ischemia. Reperfusion of the photothermolysis treated skin is inhibited by following with regular applications of phenyl-epinephrine carried in a lotion until vascular necrosis is complete. Alternatively, a temporary treatment for reddened facial skin includes only cosmetic as-needed applications of phenyl-epinephrine carried in lotion to induce vasoconstriction in Rosacea and other similarly embarrassing skin disorders.
